Work

Editorial: High‐Grade Dysplasia in Colonic Inflammatory Bowel Disease Is Associated With a High Risk of Synchronous or Metachronous Colorectal Cancer

Year: 2025

Type: editorial

Abstract: No description provided

Source: Alimentary Pharmacology & Therapeutics

DOI: 10.1111/apt.70442

Authors: Alexandra Hickey, Chaonan Dong, Christopher A. Lamb

Institutions: Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle University

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Biogen, Leona M. and Harry B. Helmsley Charitable Trust, Wellcome Trust, European Bioinformatics Institute, National Institute for Health and Care Research, Innovative Medicines Initiative, Tillotts Pharma, Nordic Pharma Group, Genentech, Medical Research Council, NIHR Newcastle Biomedical Research Centre

OpenAlex ID: W4416675840

Cites: 3

Cited by: 1

Related to: